Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS

Ruijin Hospital · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
personalizedtreatment
p53 mutation, myeloid malignancy, mds, aml, personalized treatment, decitabine, arsenic trioxide, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 804196
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.